Hamed Nayeb-Hashemi

Hamed Nayeb-Hashemi practices at SurgiThin in West Hills, California.

Hamed Nayeb-Hashemi's NPI, 1285874990, was assigned on February 20, 2009. Hamed Nayeb-Hashemi graduated from University of Pittsburgh School of Medicine in 2007. Hamed Nayeb-Hashemi holds California license A106620.

Hamed Nayeb-Hashemi's primary practice is SurgiThin, at 7320 Woodlake Avenue, Suite 300, West Hills, CA 91307. The practice phone is (818) 888-7096.

Hamed Nayeb-Hashemi's primary practice is SurgiThin in West Hills, California. Hamed Nayeb-Hashemi is also affiliated with UCLA West Valley Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Hamed Nayeb-Hashemi to 2 more hospitals, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Hamed Nayeb-Hashemi practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Hamed Nayeb-Hashemi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Hamed Nayeb-Hashemi is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Hamed Nayeb-Hashemi's licenses on file in 3 states: California, Massachusetts and Pennsylvania.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis and gastroenteritis among the conditions Hamed Nayeb-Hashemi treats.

CMS data shows 2,075 Medicare services from Hamed Nayeb-Hashemi across 19 procedure codes in 2024, for 749 Medicare patients. Medicare paid $176,179 for them.

CMS counts 749 Medicare patients who saw Hamed Nayeb-Hashemi in 2024. The largest group is 65 to 74, with 388 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Hamed Nayeb-Hashemi's median patient age at 65, with 57% women.

In 2024, Hamed Nayeb-Hashemi wrote 2,057 Medicare Part D claims for 671 patients. 83% of them were for generic drugs. CMS names the drug for 1,886 of them, across 34 drugs with 11 or more claims each, at $686,898 in total drug cost. In 2023, CMS named 1,604 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Hamed Nayeb-Hashemi for performance year 2024, reported as part of a group. Hamed Nayeb-Hashemi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Hamed Nayeb-Hashemi as offering telehealth. CMS counts 181 procedures of colonoscopy by Hamed Nayeb-Hashemi, more than 92% of the clinicians it reports for that procedure.

CMS Open Payments shows 21 general payments to Hamed Nayeb-Hashemi from 13 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. RedHill Biopharma Inc. paid the most, $1,500.

Hamed Nayeb-Hashemi graduated from University of Pittsburgh School of Medicine in 2007. Hamed Nayeb-Hashemi is a member of AGA.

Hamed Nayeb-Hashemi is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.